Post

#NarendraModi bhai shall #chill

A sight to behold, India team refused to take trophy from Pakistan Minister Mohsin Naqvi. #AsiaCup2025 #IndianWins #MohsinNaqvi

Read Ambedkar! #Ambedkar #DrBabaSahebAmbedkar #Buddhism

Welcome to SocialGraphs @rib Post your problems and praises, associate them with your leaders, public figures and organisations, pin the exact location where your problem occured in the post Feel free to post any bugs or issues you encounter to contactus@custofar.com or message your issue to @SocialGraphs #WelcomeMessage #socialgraphs

हे आई जगदम्बा, भोगवादी जीवन जगणाऱ्या आजच्या स्त्रीला दैवी दृष्टी देऊन, ईशनिष्ठ समाज व आदर्श कुटुंब बनविण्यात प्रेरित कर. || गतिस्त्वं गतिस्त्वं त्वमेका भवानी ll #aai #jagadamba

स्तंभ तुम्हाला सांगतात की, तुम्हीं कौनत्या संस्कृतिचे आहात..... #culture #संस्कृति #वैदिक

Om Namah Shivay! #Hinduism #OmNamahShivay

#Raigad #ChatrapatiShivajiMaharaj

Lenacapavir: The Six-Month HIV Revolution In the landscape of modern medicine, few challenges have been as enduring - or as transformative - as the fight against HIV. For over 40 years, scientists, clinicians, and communities have been working to outpace the virus that sparked one of the most devastating global health crises of the late 20th century. Today, we’re entering a new era. A breakthrough drug called "lenacapavir" has emerged - not just as another antiretroviral, but as a potential game-changer in how HIV is treated and prevented. Its promise? A single injection that lasts six months. That’s right: one shot, twice a year. This is more than a medical innovation. It’s a technological leap forward, one that could redefine adherence, prevention, and public health at a global scale. Let’s unpack why lenacapavir is generating so much excitement. the real magic is its longevity. After two oral loading doses, patients can switch to a subcutaneous injection that maintains protective levels for half a year. That’s twelve doses per decade—compared to 3,650 daily pills. For people living with HIV, this means less stress, fewer reminders, and improved adherence. For prevention, it could turn daily PrEP into a twice-yearly visit to the clinic, potentially transforming public health. Clinical trials have already shown lenacapavir’s power in people with multidrug-resistant HIV, where it helped many achieve undetectable viral loads. Ongoing studies suggest it could also become the most effective long-acting option for HIV prevention. Side effects are generally mild, mostly limited to injection-site reactions. The implications are massive - For treatment: freedom from daily dosing, reduced stigma, stronger viral suppression. For prevention: simpler, more accessible protection with fewer missed doses. #Lenacapavir #HIV #AIDS #HIVPreventionDrug